Yüklüyor......
Diabetes mellitus secondary to treatment with immune checkpoint inhibitors
Cancer immunotherapy has been one of the highlights in the advancement of cancer care. Certain immune checkpoint inhibitors bind to PD-1 on T cells and mediate an antitumour immune response. Given that immune checkpoint inhibitors are becoming part of standard care, a new class of adverse events—imm...
Kaydedildi:
| Yayımlandı: | Curr Oncol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Multimed Inc.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6380640/ https://ncbi.nlm.nih.gov/pubmed/30853817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4151 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|